![These highlights do not include all the information needed to use BUTRANS® safely and effectively. See full prescribing information for BUTRANS. BUTRANS® (buprenorphine) transdermal system, CIIIInitial U.S. Approval: 1981 These highlights do not include all the information needed to use BUTRANS® safely and effectively. See full prescribing information for BUTRANS. BUTRANS® (buprenorphine) transdermal system, CIIIInitial U.S. Approval: 1981](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=302919-0C+5+mcg+pouch.jpg&id=644740)
These highlights do not include all the information needed to use BUTRANS® safely and effectively. See full prescribing information for BUTRANS. BUTRANS® (buprenorphine) transdermal system, CIIIInitial U.S. Approval: 1981
![Butrans® (buprenorphine) Transdermal System CIII | What is Butrans® ( buprenorphine) Transdermal System CIII? Butrans® (buprenorphine) Transdermal System CIII | What is Butrans® ( buprenorphine) Transdermal System CIII?](https://www.butrans.com/static/chart-what-is-butran-mobile-320c228561e876d45b894b0337b55485.png)
Butrans® (buprenorphine) Transdermal System CIII | What is Butrans® ( buprenorphine) Transdermal System CIII?
![These highlights do not include all the information needed to use BUPRENORPHINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for BUPRENORPHINE TRANSDERMAL SYSTEM. BUPRENORPHINE transdermal system, CIII Initial U.S. Approval: These highlights do not include all the information needed to use BUPRENORPHINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for BUPRENORPHINE TRANSDERMAL SYSTEM. BUPRENORPHINE transdermal system, CIII Initial U.S. Approval:](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=image-26.jpg&id=725911)
These highlights do not include all the information needed to use BUPRENORPHINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for BUPRENORPHINE TRANSDERMAL SYSTEM. BUPRENORPHINE transdermal system, CIII Initial U.S. Approval:
Purdue Pharma L.P. Receives FDA Approval for 7.5 mcg/hour Dosage Strength of Butrans® (Buprenorphine) Transdermal System CIII
![Buprenorphine management in the perioperative period: educational review and recommendations from a multisociety expert panel | Regional Anesthesia & Pain Medicine Buprenorphine management in the perioperative period: educational review and recommendations from a multisociety expert panel | Regional Anesthesia & Pain Medicine](https://rapm.bmj.com/content/rapm/46/10/840/F1.large.jpg)